PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Sep-2023 Opportunity Pharma and OpenEye, Cadence Molecular Sciences join forces to power decision-making for drug discovery investors Opportunity Pharma
27-Sep-2023 Fundraising extension to >£20m for Eagle Genomics and appointment of new leadership Eagle Genomics
27-Sep-2023 Promega Developments in the Biotech Space Significantly Accelerate the Discovery Process Promega
27-Sep-2023 4SC receives Orphan Drug Designation (ODD) for resminostat (Kinselby) in CTCL from the US FDA 4SC AG
27-Sep-2023 Janssen Launches National Campaign to Recognize and Increase Support for Advanced Practice Providers Who Care for People Living with Multiple Myeloma Janssen
27-Sep-2023 DUPIXENT® (DUPILUMAB) SBLA FOR TREATMENT OF EOSINOPHILIC ESOPHAGITIS (EOE) IN CHILDREN AGED 1 TO 11 ACCEPTED FOR FDA PRIORITY REVIEW Regeneron
27-Sep-2023 palleos healthcare Advances Clinical Trial Execution with Veeva Vault Clinical Data Applications Veeva Systems
27-Sep-2023 Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services Cellectricon
27-Sep-2023 MedShr’s Digital Medical Education for Doctors Wins Hat-Trick of Awards MedShr
27-Sep-2023 GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development ProBioGen and GeoVax Labs, Inc.
27-Sep-2023 Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy Evotec SE
27-Sep-2023 Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa Cosmo Pharmaceuticals N.V.
26-Sep-2023 AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer’s conference AlzeCure
26-Sep-2023 UCB announces approval of RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in Japan UCB
26-Sep-2023 Northern Gritstone and Argobio Studio back Sheffield University spin-out Crucible Therapeutics Crucible Therapeutics
26-Sep-2023 Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review Regeneron Pharmaceuticals
26-Sep-2023 In vitro lung cell exposure systems by VITROCELL at EUROTOX 2023 VITROCELL
26-Sep-2023 Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation Acesion Pharma
26-Sep-2023 Polpharma Biologics Announces Approval of Europe’s First and Only Biosimilar for Multiple Sclerosis - Tyruko® (Natalizumab) Polpharma Biologics
26-Sep-2023 Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals Biosynth